BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+3.33%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.83B
AUM Growth
+$7.83B
(-1.8%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
2%
Top 10 Holdings %
Top 10 Hldgs %
76.26%
Holding
100
New
11
Increased
18
Reduced
12
Closed
5
Top Buys
| 1 |
Insmed
INSM
|
$217M |
| 2 |
Summit Therapeutics
SMMT
|
$181M |
| 3 |
Alkermes
ALKS
|
$101M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
$90.2M |
| 5 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$20.8M |
Top Sells
| 1 |
Incyte
INCY
|
$330M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$62.1M |
| 3 |
Roivant Sciences
ROIV
|
$48.8M |
| 4 |
Akero Therapeutics
AKRO
|
$37.9M |
| 5 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$37.5M |
Sector Composition
| 1 | Healthcare | 98.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Athira Pharma
ATHA
$15.5M
| $8.36M | 0.11% |
3,153,807
| – | – |
|
|
VERV
52
DELISTED
Verve Therapeutics
VERV
| $8.25M | 0.11% |
1,691,530
| – | – |
|
53
Relay Therapeutics
RLAY
$709M
| $7.56M | 0.1% |
1,160,117
| – | – |
|
54
Mirum Pharmaceuticals
MIRM
$3.75B
| $6.51M | 0.08% |
190,476
| – | – |
|
55
Tango Therapeutics
TNGX
$745M
| $6.44M | 0.08% |
750,000
| – | – |
|
56
KALA BIO
KALA
$105M
| $6.32M | 0.08% |
891,335
+624,722
| +234% | +$4.43M |
|
|
DBVT
57
DBV Technologies
DBVT
$249M
| $5.85M | 0.07% |
7,307,131
-7,307,133
| -50% | – |
|
58
Design Therapeutics
DSGN
$339M
| $5.68M | 0.07% |
1,695,294
+33,174
| +2% | +$111K |
|
|
CTNM
59
Contineum Therapeutics
CTNM
$297M
| $5.5M | 0.07% |
+312,500
| New | +$5.5M |
|
60
Praxis Precision Medicines
PRAX
$980M
| $5.44M | 0.07% |
131,533
| – | – |
|
61
CRISPR Therapeutics
CRSP
$4.82B
| $5.4M | 0.07% |
+100,000
| New | +$5.4M |
|
62
Prime Medicine
PRME
$595M
| $5.29M | 0.07% |
1,028,466
| – | – |
|
|
CNTA
63
Centessa Pharmaceuticals
CNTA
$2.13B
| $4.96M | 0.06% |
+549,212
| New | +$4.96M |
|
|
HOOK
64
DELISTED
HOOKIPA Pharma
HOOK
| $4.81M | 0.06% |
8,128,151
| – | – |
|
65
Sagimet Biosciences
SGMT
$239M
| $4.73M | 0.06% |
1,381,898
| – | – |
|
66
Crinetics Pharmaceuticals
CRNX
$3.26B
| $4.65M | 0.06% |
+103,927
| New | +$4.65M |
|
|
TLIS
67
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $4.4M | 0.06% |
508,323
| – | – |
|
68
Alector
ALEC
$282M
| $4.21M | 0.05% |
+927,264
| New | +$4.21M |
|
|
OPT
69
DELISTED
Opthea Limited American Depositary Shares
OPT
| $4.2M | 0.05% |
2,173,622
-4,204
| -0.2% | -$8.11K |
|
70
Skye Bioscience
SKYE
$104M
| $4.01M | 0.05% |
+500,000
| New | +$4.01M |
|
71
Vaxcyte
PCVX
$4.17B
| $3.69M | 0.05% |
48,885
| – | – |
|
72
Arcturus Therapeutics
ARCT
$467M
| $3.68M | 0.05% |
+151,329
| New | +$3.68M |
|
73
Generation Bio
GBIO
$40.3M
| $3.4M | 0.04% |
1,206,957
+835,738
| +225% | +$2.36M |
|
74
Enliven Therapeutics
ELVN
$1.24B
| $2.68M | 0.03% |
114,833
| – | – |
|
75
Leap Therapeutics
LPTX
$12M
| $2.3M | 0.03% |
1,172,175
| – | – |
|